Historical record - last NADAC effective date: 7/17/2024

Product Information

IBANDRONATE SODIUM 150 MG TAB is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $3.2323 per EA under NDC 55111057503. Its NADAC has been published 558 times since Nov 28, 2013.

FDA first approved this application on Apr 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBANDRONATE SODIUM 150 MG TAB

Ibandronate sodium
$3.2323per EA

Strength

150 mg/1

NDC

55111057503

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

7/17/2024

Active Ingredients

IBANDRONATE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA078997

FDA Approved

4/30/2012

TE Code

AB

On Market Since

6/21/2012

Pharmacological Classes

Bisphosphonate
Diphosphonates

Price Statistics

The NADAC for IBANDRONATE SODIUM 150 MG TAB has been published 558 times since Nov 28, 2013, and over the history we have for it it has declined 92.8%. The table below summarizes its recorded NADAC range and movement.

Current price$3.2323 per EA
All-time high$44.9978 (Dec 11, 2013)
All-time low$3.2323 (Jul 17, 2024)
Median price$6.7212
Average price$12.9399
Largest weekly change-23.4% (Jan 18, 2017)
Weeks tracked558
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-19.2%

5Y

-46.6%

All

-92.8%

Last surveyed Jul 31, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 15%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of IBANDRONATE SODIUM 150 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for IBANDRONATE SODIUM 150 MG TAB, manufactured by Dr. Reddy's Laboratories Inc., is $3.2323 per EA (NDC 55111057503), effective Jul 31, 2024.

How has the price of IBANDRONATE SODIUM 150 MG TAB changed over time?

Over the history we have for it, the NADAC for IBANDRONATE SODIUM 150 MG TAB has declined 92.8%. It has been tracked across 558 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for IBANDRONATE SODIUM 150 MG TAB?

Since Nov 28, 2013, the NADAC for IBANDRONATE SODIUM 150 MG TAB has ranged from a low of $3.2323 (Jul 17, 2024) to a high of $44.9978 (Dec 11, 2013), with a median of $6.7212 per EA.

Are there cheaper alternatives to IBANDRONATE SODIUM 150 MG TAB?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBANDRONATE SODIUM 150 MG TAB, is $2.7524 per EA — about 15% below IBANDRONATE SODIUM 150 MG TAB.

Who manufactures IBANDRONATE SODIUM 150 MG TAB?

IBANDRONATE SODIUM 150 MG TAB (NDC 55111057503) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.